NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 59 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,412,000 | – | 5,003,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aequim Alternative Investments LP | 24,000,000 | $30,877,000 | 5.11% |
| Alken Asset Management Ltd | 360,000 | $457,000 | 1.90% |
| III Capital Management | 3,500,000 | $4,481,000 | 1.64% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,920,000 | $5,113,000 | 0.76% |
| CSS LLC/IL | 6,842,000 | $8,745,000 | 0.69% |
| DeepCurrents Investment Group LLC | 10,408,000 | $13,373,000 | 0.65% |
| SSI INVESTMENT MANAGEMENT LLC | 4,334,000 | $5,554,000 | 0.49% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,250,000 | $23,476,000 | 0.34% |
| MACKAY SHIELDS LLC | 24,612,000 | $31,641,000 | 0.29% |
| Nicholas Investment Partners, LP | 1,115,000 | $1,429,000 | 0.28% |